Trevi Therapeutics
TRVI
#6350
Rank
A$0.96 B
Marketcap
$10.01
Share price
-2.73%
Change (1 day)
111.36%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.47

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.51. In 2022 the company made an earnings per share (EPS) of -$0.93 an increase over its 2021 EPS that were of -$2.48.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.47-49.53%
2022-$0.93-62.67%
2021-$2.48-17.29%
2020-$3.0018.17%
2019-$2.54-46.21%
2018-$4.72